Correct option is (b) An effector cell
The best I can explain: It is possible to design bispecific antibodies. Bispecific antibodies can either bind to 2 antigen or bind with antigen and with another effector cell/conjugate cell. By binding with effector cell, it increases the efficacy of the reactions to happen and thus more chances of getting positive results.